Clindamycin in 5 Percent Dextrose

Clindamycin in 5 Percent Dextrose · CLINDAMYCIN 18 mg/mL · Injection, Solution · Intravenous · Civica, Inc.

NDC 72572-0076-24 · 24 BAG in 1 CARTON / 50 mL in 1 BAG · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00781-3290-09) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built

Data sources

CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)

Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ

$0.2266per unit

middle half $0.2059–$0.2300 · 5,101 plans · Apr 1, 2026

Est. net of rebatesⓘ

≈ $0.2266

generic — rebates are minimal, so net ≈ gross

Coverage & restrictions

93%of plans cover it

tier 4 · prior auth 8% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$120.00

Reported to Texas DSHS · 2026 annual filing · Civica, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 300 MG

$1.974

HCPCS J0736 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$10

54 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA201692
TE code: AP
Approval date: May 31, 2012
Patents / exclusivity: None on file

Shortage history

In shortage now — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Mar 21, 2023
month 42 — 2× the typical 20-month injectable shortage
In shortage now — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Mar 21, 2023
month 42 — 2× the typical 20-month injectable shortage
In shortage now — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Mar 21, 2023
month 42 — 2× the typical 20-month injectable shortage
In shortage now — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Mar 21, 2023
month 42 — 2× the typical 20-month injectable shortage
In shortage now — Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Mar 21, 2023
month 42 — 2× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clindamycin in 5 Percent Dextrose (Injection, Solution)

Labeler	Strength	First seen	Last seen
Civica, Inc.	CLINDAMYCIN 18 mg/mL	Jul 15, 2026	Sep 2, 2026
Civica, Inc.	CLINDAMYCIN 12 mg/mL	Jul 15, 2026	Sep 2, 2026
Hikma Pharmaceuticals USA Inc.	CLINDAMYCIN 18 mg/mL	Jul 15, 2026	Sep 2, 2026
Hikma Pharmaceuticals USA Inc.	CLINDAMYCIN 12 mg/mL	Jul 15, 2026	Sep 2, 2026
Sandoz Inc	CLINDAMYCIN 12 mg/mL	Jul 15, 2026	Sep 2, 2026
Sandoz Inc	CLINDAMYCIN 6 mg/mL	Jul 15, 2026	Sep 2, 2026
Sandoz Inc	CLINDAMYCIN 18 mg/mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clindamycin in 5 Percent Dextrose — NDC 72572-0076-24," retrieved September 3, 2026, https://drugdashboards.com/drug/72572007624.

Free to cite with attribution — see how the data is put together.